SCHEMBL23927916

SCHEMBL23927916

Cc1cc2ccccc2n1CC(OC(=O)/C=C/C(=O)OC(Cn1c(C)cc2ccccc21)N(C)C)N(C)C

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 6/20 0.44
KMT2A Q03164 6/20 0.44
HTT P42858 3/20 0.44
TP53 P04637 4/20 0.44
KDM4E B2RXH2 3/20 0.44
HDAC1 Q13547 1/20 0.44
HDAC2 Q92769 1/20 0.44
HDAC8 Q9BY41 1/20 0.44
HDAC6 Q9UBN7 1/20 0.44
HDAC9 Q9UKV0 1/20 0.44
TSHR P16473 3/20 0.43
MAPT P10636 8/20 0.42
SMN1; SMN2 Q16637 6/20 0.42
ALDH1A1 P00352 2/20 0.42
CYP1A2 P05177 2/20 0.42
CYP3A4 P08684 2/20 0.42
CYP2D6 P10635 2/20 0.42
CYP2C19 P33261 2/20 0.42
NPC1 O15118 1/20 0.42
HSP90AA1 P07900 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23927878 0.81 DNM1 (0.48) MEN1KMT2AHTTKDM4ETSHR
SCHEMBL23927824 0.78 KMT2A (0.44) MEN1KMT2ATP53KDM4EHDAC1
SCHEMBL11696617 0.73 KDM4E (0.52) MEN1KMT2AHTTTP53KDM4E
Fumaric Acid SCHEMBL28678836 0.72 MEN1 (0.51) MEN1KMT2AHTTTP53KDM4E
SCHEMBL11695862 0.71 TP53 (0.50) MEN1KMT2AHTTTP53KDM4E
SCHEMBL23927901 0.71 HTR2A (0.48) MEN1KMT2AHTTTP53SMN1; SMN2
SCHEMBL23927819 0.70 HTR2C (0.50) HDAC1HDAC2HDAC8HDAC6HDAC9
SCHEMBL11506155 0.70 PRMT5 (0.54) MEN1KMT2AHTTTP53KDM4E
SCHEMBL23927862 0.70 HCAR2 (0.33) MEN1KMT2A
SCHEMBL11698566 0.69 MEN1 (0.48) MEN1KMT2AHTTTP53KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11254640-B2 N-substituted indoles and other heterocycles for treating brain disorders THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2022-02-22 US disclosed
US-20210332012-A1 N-SUBSTITUTED INDOLES AND OTHER HETEROCYCLES FOR TREATING BRAIN DISORDERS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA CORPORATION 2021-10-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11254640-B2 N-substituted indoles and other heterocycles for treating brain disorders TPH2, AANAT, HTR2C MEN1 995/4885KMT2A 542/4885HTT 37/4885
US-20210332012-A1 N-SUBSTITUTED INDOLES AND OTHER HETEROCYCLES FOR TREATING BRAIN DISORDERS TPH2, AANAT, HTR2C MEN1 995/4885KMT2A 542/4885HTT 37/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.